|Bid||0.00 x 800|
|Ask||0.00 x 39400|
|Day's Range||72.32 - 74.57|
|52 Week Range||60.14 - 83.88|
|Beta (3Y Monthly)||1.03|
|PE Ratio (TTM)||24.13|
|Earnings Date||Feb 6, 2019 - Feb 11, 2019|
|Forward Dividend & Yield||2.00 (2.70%)|
|1y Target Est||93.15|
Asian markets tumbled on Friday after China reported weaker-than-expected economic data, stirring up worries about the state of the world's second largest economy. KEEPING SCORE: Japan's Nikkei 225 index slid 1.7 percent to 21,439.16 and the Kospi in South Korea lost 1.2 percent to 2,070.70.
Amazon (AMZN) stock has fallen over 16% in the last three months as part of the larger market pullback driven by the likes of Apple (AAPL) and other giants. The company's days of 40% top-line growth might also be over. But let's dive into Amazon's overall business picture and outlook to see if investors should buy AMZN stock heading into 2019.
Stocks that moved substantially or traded heavily Thursday: CVS Health Corp., down $1.13 to $73.37 The New York Post reported that a judge might bar CVS from integrating its business with health insurer ...
The Dow Jones Industrial Average rose Thursday as Wall Street expressed optimism over U.S. and China trade talks. said Thursday it would invest $1 billion to build a new campus in Austin, Texas. Stocks traded mixed on Thursday, Dec. 13, as Wall Street monitored trade developments between the U.S. and China, the world's two largest economies.
Jason Moser’s pick for the contest is Teladoc Health (NASDAQ:TDOC). Thankfully, virtual healthcare provider Teladoc Health (NASDAQ:TDOC) is leveraging medical expertise to impact consumers around the world and offer them more options in a market which seems mired in red tape. While the concept of telehealth is still new to many, it is being seen more and more as an excellent option in many cases and the investments Teladoc is making in its business today could pay off big down the road as telehealth becomes a more meaningful part of the overall healthcare industry.
U.S. stock futures were mixed on Thursday, Dec. 13, and shares in Asia closed higher as trade tensions eased between the U.S. and China, the world's two largest economies. Wall Street finished higher on Wednesday, Dec. 12, as investors cheered progress in U.S.-China trade talks and after a report said China was planning a new program that promised greater access for foreign companies. The Wall Street Journal reported Wednesday that China was drafting a replacement for Made in China 2025 - President Xi's blueprint to make the country a leader in high-tech industries - which would play down China's bid to dominate manufacturing and be more open to participation by foreign companies.
Dividend growth stocks have obvious appeal. After all, dividend investing is based on buying and holding a stock for the payouts. Unlike traditional growth investing, where you depend on a stock increasing in value based on profits or sales trends, dividend investing focuses on the payouts above all else.
CVS Health (CVS) estimates a $750-million earning from near-term synergies with low- to mid-single digit addition in the second year after the closure of Aetna transaction.
CVS Health acquired health insurance giant Aetna for about $70 billion. CVS has bought other pharmacies to build its footrprint, as well as pharmacy benefit manager Caremark and walk-in health clinic MinuteClinic. It's buying a health insurer to prove it.
To start 2018, many on Wall Street were predicting a great year for stocks, as Donald Trump's tax plan was expected to produce elevated mergers and acquisitions activity. The deal activity has certainly been a part of the 2018 story, but the trend could slow down in 2019, said analysts from Goldman Sachs. Deal announcements are expected to increase 20% year over year in 2018, according to a note from Goldman that was released Tuesday.
The latest list of new buys by the best mutual funds shows a focus on large cap stocks like Berkshire, led by Warren Buffett, CVS, Starbucks and Adobe.
Is CVS Health Corporation (NYSE:CVS) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from industry insiders. They sometimes fail miserably but historically their consensus stock picks outperformed the market […]
Walgreens Boots Alliance Inc. has teamed up with FedEx Corp. to launch a nationwide next-day prescription home-delivery service as the drugstore chain works to stave off competition from Amazon.com Inc. and other rivals. Under the delivery service called Walgreens Express, patients enrolled in text alerts will receive text notification when qualifying prescriptions are ready, Walgreens said Thursday. For a $4.99 fee, patients can have their prescriptions delivered by FedEx to their home as early as the next day.
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In the race to make inroads in the on-demand drug delivery space, Walgreens' move could potentially put it head-to-head with Amazon.com Inc, which earlier this year said it would buy online pharmacy PillPack. Amazon's entry in the market would rattle traditional drug retailers and could potentially disrupt major players the U.S. drug supply chain. Rival CVS Health Corp launched its own next-day delivery service earlier this year.
Walgreens is joining rival drugstore chain CVS Health in expanding home deliveries for prescriptions nationwide, as stores continue adjusting to a retail world made more consumer-friendly by online competition. Walgreens said Thursday it will partner with FedEx to deliver prescriptions as soon as the next day for a $4.99 fee, and it also is providing same-day deliveries in several cities including New York, Chicago and Dallas. Walgreens and FedEx Corp. began a partnership last year where the drugstore chain started offering package drop-off and pick-up services at several thousand stores.
Walgreens Boots Alliance said on Thursday it would partner with FedEx Corp to launch a next-day delivery service for prescription drugs nationwide, giving it a leg up as Amazon threatens to shake-up the sector. In the race to make inroads in the on-demand drug delivery space, Walgreens' move could potentially put it head-to-head with Amazon.com Inc, which earlier this year said it would buy online pharmacy PillPack. Amazon's entry in the market would rattle traditional drug retailers and could potentially disrupt major players the U.S. drug supply chain.
The company announced a new pricing model for its pharmacy benefit management services Wednesday morning. The White House has been an active critic of PBMs, which negotiate drug discounts on behalf of employers and health plans, arguing that they have distorted the drug-pricing system. Drugmakers pay rebates than can amount to more than 50 percent of a drug’s sticker price to secure favorable coverage on PBM drug lists, and critics contend that firms like CVS keep an excessive slice of those undisclosed payments.